Literature DB >> 10465698

The developmental expression and activity of peptidylarginine deiminase in the mouse.

L B Pritzker1, T A Nguyen, M A Moscarello.   

Abstract

We have measured the expression and activity of peptidylarginine deiminase (PAD, EC 3.5.3.15), the enzyme responsible for converting arginyl residues in proteins to citrullines, in normal mouse brain homogenate. PAD transcripts were detected as early as five days and were maximal at one month of age. The enzyme protein was also detected at 5 days in an antibody dependent assay and was maximal at 2 months of age, 1 month later than the maximum expression of transcripts. As expected, enzyme activity had a similar developmental profile to that of the enzyme protein. In isolated mouse brain compact myelin, the activity was highest at 15 days and fell rapidly to 15% of this level by 1-2 months. In the 'loose' myelin fraction (heavy myelin) it remained at the same high level form from 15 days to 8 months. The activity in compact myelin was about 15 times greater than the activity in brain homogenate, suggesting much of the enzyme was localized to myelin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465698     DOI: 10.1016/s0304-3940(99)00276-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

Review 1.  Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation.

Authors:  Erin E Witalison; Paul R Thompson; Lorne J Hofseth
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 2.  The clinical significance of posttranslational modification of autoantigens.

Authors:  Maria G Zavala-Cerna; Erika A Martínez-García; Olivia Torres-Bugarín; Benjamín Rubio-Jurado; Carlos Riebeling; Arnulfo Nava
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

3.  N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.

Authors:  Van C Willis; Alison M Gizinski; Nirmal K Banda; Corey P Causey; Bryan Knuckley; Kristen N Cordova; Yuan Luo; Brandt Levitt; Magdalena Glogowska; Piyanka Chandra; Liudmila Kulik; William H Robinson; William P Arend; Paul R Thompson; V Michael Holers
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

Review 4.  A tale of two citrullines--structural and functional aspects of myelin basic protein deimination in health and disease.

Authors:  George Harauz; Abdiwahab A Musse
Journal:  Neurochem Res       Date:  2006-08-09       Impact factor: 3.996

5.  Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis.

Authors:  V C Willis; N K Banda; K N Cordova; P E Chandra; W H Robinson; D C Cooper; D Lugo; G Mehta; S Taylor; P P Tak; R K Prinjha; H D Lewis; V M Holers
Journal:  Clin Exp Immunol       Date:  2017-03-09       Impact factor: 4.330

6.  PADI4 and tumourigenesis.

Authors:  Xiaotian Chang; Kehua Fang
Journal:  Cancer Cell Int       Date:  2010-03-12       Impact factor: 5.722

7.  Mining the Human Tissue Proteome for Protein Citrullination.

Authors:  Chien-Yun Lee; Dongxue Wang; Mathias Wilhelm; Daniel P Zolg; Tobias Schmidt; Karsten Schnatbaum; Ulf Reimer; Fredrik Pontén; Mathias Uhlén; Hannes Hahne; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2018-04-02       Impact factor: 5.911

8.  PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.

Authors:  Maria Guadalupe Zavala-Cerna; Norma Guadalupe Gonzalez-Montoya; Arnulfo Nava; Jorge I Gamez-Nava; Maria Cristina Moran-Moguel; Roberto Carlos Rosales-Gomez; Susan Andrea Gutierrez-Rubio; Jose Sanchez-Corona; Laura Gonzalez-Lopez; Ingrid Patricia Davalos-Rodriguez; Mario Salazar-Paramo
Journal:  Clin Dev Immunol       Date:  2013-12-22

9.  PADI2 gene confers susceptibility to breast cancer and plays tumorigenic role via ACSL4, BINC3 and CA9 signaling.

Authors:  Huifeng Wang; Bing Xu; Xiaoqian Zhang; Yabing Zheng; Yan Zhao; Xiaotian Chang
Journal:  Cancer Cell Int       Date:  2016-07-29       Impact factor: 5.722

10.  PADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levels.

Authors:  Yabing Zheng; Gang Zhao; Bing Xu; Chunyan Liu; Chang Li; Xiaoqian Zhang; Xiaotian Chang
Journal:  Oncotarget       Date:  2016-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.